News and Views
Recent Price Movement and Market Performance
Samrat Pharmachem’s shares have been under pressure, hitting a new 52-week low of Rs. 210 on the day. The stock opened sharply lower with a gap down of 5.2%, signalling immediate bearish sentiment among investors. Over the past week, the stock has declined by 7.7%, significantly underperforming the Sensex’s modest 1.83% fall. This negative momentum extends over longer periods as well, with the stock falling 16.61% in the last month compared to the Sensex’s 1.63% decline, and a year-to-date loss of 5.39% against the benchmark’s 1.58% drop.
More concerning is the stock’s long-term underperformance. Over the past year, Samrat Pharmachem has delivered a steep negative return of 39.64%, while the Sensex has gained 8.4%. Over thre...
Read full news article
